相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The failure of torcetrapib: What have we learned?
T. R. Joy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
M. J. Forrest et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials
Menno Vergeer et al.
CIRCULATION (2008)
The failure of torcetrapib: is there a case for independent preclinical and clinical testing? - author's reply
Sheila A. Doggrell
EXPERT OPINION ON PHARMACOTHERAPY (2008)
The failure of torcetrapib: is there a case for independent preclinical and clinical testing? - correspondence
Charles L. Shear
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
Alexander Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Analysis of Recent Papers in Hypertension Jan Basile, MD, Senior Editor
Michael J. Bloch et al.
Journal of Clinical Hypertension (2008)
Common variation in the CETP gene and the implications for cardiovascular disease and its treatment:: an updated analysis
Robin P. F. Dullaart et al.
PHARMACOGENOMICS (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
Michiel L. Bots et al.
LANCET (2007)
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia
John J. P. Kastelein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides
Susanna E. Borggreve et al.
EUROPEAN HEART JOURNAL (2007)
Effect of torcetrapib on the progression of coronary atherosclerosis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular regulation of HDL metabolism and function: implications for novel therapies
Daniel J. Rader
JOURNAL OF CLINICAL INVESTIGATION (2006)
The potential for CETP inhibition to reduce cardiovascular disease risk
Benjamin Ansell et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: A population-based study
Susanna E. Borggreve et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin
P. Marschang et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Modulation of plasma cholesteryl ester transfer protein activity by unsaturated fatty acids in Tunisian type 2 diabetic women
M Smaoui et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2006)
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly
JD Curb et al.
JOURNAL OF LIPID RESEARCH (2004)
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol
ME Brousseau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib
RW Clark et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study
SM Boekholdt et al.
CIRCULATION (2004)
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans
CC Schwartz et al.
JOURNAL OF LIPID RESEARCH (2004)
A review of CETP and its relation to atherosclerosis
GJ de Grooth et al.
JOURNAL OF LIPID RESEARCH (2004)
Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects
K Ikewaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
SM Boekholdt et al.
JOURNAL OF LIPID RESEARCH (2003)
Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes
FV van Venrooij et al.
DIABETES CARE (2003)
Cholesteryl ester transfer protein - A novel target for raising HDL and inhibiting atherosclerosis
PJ Barter et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency -: Veterans Affairs HDL Cholesterol Intervention Trial
ME Brousseau et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans - A randomized phase II dose-response study
GJ de Grooth et al.
CIRCULATION (2002)
分享论文
